1Coello MC,Luketich JD,Litle VR,et al.Prognostic significance of micrometastasis in non-small-cell lung cancer.Clin Lung Cancer,2004,5:214-225.
2Rosell R,Felip E,Maestre J,et al.The role of chemotherapy in early non-small-cell lung cancer management.Lung Cancer,2001,34 Suppl 3:S63-S74.
3Felip E,Rosell R.Neoadjuvant chemotherapy in non-small cell lung cancer.Curr Med Chem,2002,9:893-898.
4Mitas M,Hoover L,Silvestri G,et al.Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood[corrected].J Mol Diagn,2003,5:237-242.
5Herbst RS,Sandler AB.Overview of the current status of human epidermal growth factor receptor inhibitors in lung cancer.Clin Lung Cancer,2004,6 Suppl 1:S7-S19.
6Clarke LE,Leitzel K,Smith J,et al.Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic,lung,and colon carcinomas detected by RT-PCR.Int J Oncol,2003,22:425-430.
7Tomizawa Y,Iijima H,Nomoto T,et al.Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24,RASSF1A at 3p21.3,and FHIT at 3p14.2 in patients with non-small cell lung cancer.Lung Cancer,2004,46:305-312.
8Roz L,Gramegna M,Ishii H,et al.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.Proc Natl Acad Sci U S A,2002,99:3615-3620.
9Sozzi G,Conte D,Leon M,et al.Quantification of free circulating DNA as a diagnostic marker in lung cancer.J Clin Oncol,2003,21:3902-3908.
10Ikuta K,Takemura K,Kihara M,et al.Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.Oncol Rep,2005,13:217-222.
6Yuri Shimanuki,Kazuhisa Takahashi,Ri Cui,Satoshi Hori,Fumiyuki Takahashi,Hideaki Miyamoto,Yoshinosuke Fukurchi. Role of Serum Vascular Endothelial Growth Factor in the Prediction of Angiogenesis and Prognosis for Non-small Cell Lung Cancer[J] 2005,Lung(1):29～42
